ACQUISITION (Details) - USD ($) |
1 Months Ended | 12 Months Ended |
|---|---|---|
Feb. 26, 2025 |
Jun. 30, 2026 |
|
| Business Combination [Line Items] | ||
| Total consideration transferred | $ 1,840,000 | |
| Bio Symetricsnc Acquisition [Member] | ||
| Business Combination [Line Items] | ||
| Common stock | $ 6,058,500 | |
| Total consideration transferred | $ 6,058,500 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|